![]() Stemline Therapeutics Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells. | ||
Founding Date | Founding Date 2003 | Founding Date 1994 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations New York, US HQ | Locations Alameda, US HQ |
Employees | Employees 100 | Employees 1,14712% decrease |
Valuation ($) | Valuation ($) 621.2 m | Valuation ($) 8.2 b |
Financial | ||
Cost of goods | Cost of goods $4.9m (FY, 2019) | Cost of goods $83.7m (FY, 2025) |
Net income | Net income ($76.8m) (FY, 2019) | Net income $782.6m (FY, 2025) |

Exelixis is an oncology company that develops cancer treatments.
View company